BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 18037256)

  • 1. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor and its soluble receptor in ovarian pathology.
    Artini PG; Cristello F; Monti M; Cela V; Battaglia C; D'Ambrogio G; Genazzani AR
    Gynecol Endocrinol; 2005 Jul; 21(1):50-6. PubMed ID: 16048802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D; Nicosia RF; Nicosia SV
    Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis.
    Bourlev V; Iljasova N; Adamyan L; Larsson A; Olovsson M
    Fertil Steril; 2010 Jun; 94(1):52-7. PubMed ID: 19324337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain.
    García-Manero M; Alcazar JL; Toledo G
    Fertil Steril; 2007 Aug; 88(2):513-5. PubMed ID: 17296185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
    Sun LX; Wu Y; Han HQ; Wang QH
    Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer.
    Cobellis L; Reis FM; Luisi S; Danero S; Pirtoli L; Scambia G; Petraglia F
    J Soc Gynecol Investig; 2004 May; 11(4):203-6. PubMed ID: 15120692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
    Harlozinska A; Sedlaczek P; Kulpa J; Grybos M; Wójcik E; Van Dalen A; Einarsson R
    Anticancer Res; 2004; 24(2C):1149-57. PubMed ID: 15154640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata.
    Goteri G; Lucarini G; Filosa A; Pierantoni A; Montik N; Biagini G; Fabris G; Ciavattini A
    Fertil Steril; 2004 Jun; 81(6):1528-33. PubMed ID: 15193472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) is decreased in lung cancer patients showing progression: a pilot study.
    Yilmaztepe A; Ulukaya E; Zik B; Yagci A; Sevimli A; Yilmaz M; Erdogan BB; Koc M; Akgoz S; Karadag M; Tokullugil A
    Cancer Invest; 2007 Aug; 25(5):322-7. PubMed ID: 17661207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining.
    Garzetti GG; Ciavattini A; Lucarini G; Pugnaloni A; De Nictolis M; Amati S; Romanini C; Biagini G
    Gynecol Oncol; 1999 Jun; 73(3):396-401. PubMed ID: 10366466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.